-The Times of India India is all set to weed out and check the ever mushrooming clinics involved in renting a womb or carrying out Assisted Reproductive Technology (ART).  The Assisted Reproductive Technology Regulation Bill, prepared by the Indian Council of Medical Research (ICMR), will make it mandatory for all clinics involved in treating infertility through procedures like artificial insemination with husband's semen (AIH) or in-vitro fertilization-embryo transfer (IVF) to get registered...

MANMOHAN SINGH AND ECONOMICS Sanjaya Baru’s article "The economist as saviour", an account of Prime Minister Manmohan Singh’s economics could have juxtaposed specific issues of economic policy with Dr. Singh’s stance on them. Sanjaya Baru’s article “The economist as saviour” (editorial page, The Hindu, July 4, 2012), an account of Prime Minister Manmohan Singh’s economics could have juxtaposed specific issues of economic policy with Dr. Singh’s stance on them. What we...

-The Telegraph Environmental activists have criticized the outcome of the recently concluded Rio+20 summit as insubstantial. They are not wrong, but they have missed the main point. There was a very real danger that, far from registering progress, the summit would actually mark a giant step backwards for sustainable development. Rich and powerful countries made a concerted attempt to actually undo and reverse the advances that were achieved 20 years ago...

-The Hindu Unsustainable import competition and the end of the investment subsidy that the sale of under-priced resources provided to Indian companies are the main reasons why the economy has slowed down What has been called the ‘golden age’ of India’s economic growth was underpinned by global integration, high rates of investment and savings growth and low current account deficits. The slowdown is characterised by a sharp deceleration in investment growth on...

-The Economic Times It's not just the drug regulator, where a parliamentary panel has alleged corruption, failing in its job. Drug regulation across entities that dot this broad landscape is in poor health and ineffective. In May, when a Parliamentary panel, during a routine examination of healthcare regulatory bodies, alleged corruption in the approval of new drugs, it was merely pointing out one symptom. Such symptoms pervade the entire drug regulation landscape,...